UCB reported EUR2.44 in EPS Earnings Per Share for its fiscal semester ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025H1 Jun/2025 2.44 2.09 Jul/31 2025
FY2024H2 Dec/2024 2.89 1.57 Feb/28 2025
FY2024H1 Jun/2024 2.09 1.81B 2.63 Jul/25 2024
FY2023H2 Dec/2023 1.57 1.22 Feb/28 2024
FY2023H1 Jun/2023 2.63 1.74 3.15 Jul/27 2023
FY2022H2 Dec/2022 1.22 1.04 3.09 Feb/22 2023
FY2022H1 Jun/2022 3.15 2.48 3.4 Jul/28 2022
FY2021H2 Dec/2021 3.09 2.66 2.59 Feb/24 2022
FY2021H1 Jun/2021 3.40 2.97 2.77 Jul/29 2021
FY2020H2 Dec/2020 2.59 2.16 2.78 Feb/25 2021
FY2020H1 Jun/2020 2.77 2.87 2.42 Jul/27 2020
FY2019H2 Dec/2019 2.78 2.53 1.7 Feb/20 2020


Eps Change Date
Alcon AG USD 0.76 0.03 Jun/2025
Almirall EUR 0.02 0.08 Jun/2025
Amarin USD -0.03 0.01 Jun/2025
argenx SE USD 3.26 0.99 Jun/2025
AstraZeneca USD 2.17 0.32 Jun/2025
Bayer EUR 1.23 1.26 Jun/2025
Galapagos EUR -0.25 2.1 Jun/2025
Genmab DKK 34.31 14.07 Jun/2025
GlaxoSmithKline GBP 0.47 0.02 Jun/2025
GRIFOLS EUR 0.19 0.05 Jun/2025
Hikma Pharmaceutical USD 0.6 0.41 Dec/2024
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 1.76 0.36 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Orion EUR 0.59 0.15 Jun/2025
Recordati EUR 0.74 0.14 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Sanofi EUR 1.59 0.21 Jun/2025
UCB EUR 2.44 0.45 Jun/2025
Unibail Rodamco EUR 4.71 0.43 Dec/2024